| Last Trade (%) | 133.20 |
| Change | (0.60) |
| Change (%) | (0.45) |
| Open | 133.80 |
| Low | 132.40 |
| High | 134.00 |
| Prev. Close | 133.80 |
| Change (3M) | 7.59 % |
| Change (6M) | (9.76 %) |
| Volume | 26,729 |
| Turnover | 3,554,027.00 |
| Transactions | 581 |
| Market Value | 2,664.00 |
| Avg. Volume (3M) | 134,936.69 |
| Avg. Turnover (3M) | 17,864,683.20 |
| Avg. Transaction (3M) | 1,535.77 |
| Change (12M) | n/a |
| YTD | n/a |
|
Event Date
|
Event
|
Venue
|
|
|---|---|---|---|
|
15-09-2024
|
Cash Dividend Distribution | - | |
|
01-09-2024
|
Ex-dividend Date | - | |
|
30-06-2024
|
General Assembly | - | |
|
27-02-2024
|
listing date | - | |
|
14-02-2024
|
Surplus refund date | - | |
| More | |||
| Report | Interim | Year |
| Avalon Pharma’s profit rises 78% to SAR 31.2M in H1 2024; Q2 at SAR 21.8M | 6 M | 2024 |
| Avalon Pharma turns to profit of SAR 9.4M in Q1 2024 | 3 M | 2024 |
| Avalon Pharma’s profit rises 11% to SAR 65.8M in 2023 | 12 M | 2023 |
| Date | Research firm | Rating |
|
|
Al Rajhi Capital | Neutral |
|
|
Al Rajhi Capital | Underweight |
|
|
Al Rajhi Capital | Overweight |
|
|
GIB Capital | Overweight |
